Bostwick Laboratories Company Description
Nobody wants to hear that it's cancer, but Bostwick Laboratories at least tries to get the news to you quick -- within 24 hours on average. The pathology lab focuses on diagnosing cancer; most of its revenue comes from analyzing prostate biopsies and urine tests but it is expanding into gynecology, gastroenterology, and kidney diagnostics. It has half a dozen labs in the US and one in the UK offering services in the diagnosis, treatment, prevention, and management of cancer. Its Bostwick Scientific division also provides clinical trial support to pharmaceutical and biotechnology firms. CEO Dr. David Bostwick, a former professor of pathology and urology at the Mayo Clinic, formed Bostwick Laboratories in 1999.
View the Comprehensive Company Description for Bostwick Laboratories
The Company Description provides a historical perspective of Bostwick Laboratories's organization from inception to current status.
Produced by Hoover's in-house editorial team, the Company Description tracks ownership transitions, company progress via mergers and acquisitions, major growth milestones, and strategic initiatives, to provide a holistic view of Bostwick Laboratories's evolution in the marketplace.
